Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

1.62

Today's Change

+0.01 (0.62%)

Day's Change

1.59 - 1.64

Trading Volume

2,066,120

Overview

Market Cap

585 Million

Shares Outstanding

361 Million

Avg Volume

3,670,723

Avg Price (50 Days)

1.93

Avg Price (200 Days)

1.66

PE Ratio

-1.95

EPS

-0.83

Earnings Announcement

01-Aug-2024

Previous Close

1.61

Open

1.63

Day's Range

1.59 - 1.64

Year Range

0.92 - 3.73

Trading Volume

2,066,120

Price Change Highlight

1 Day Change

0.62%

5 Day Change

-3.57%

1 Month Change

2.53%

3 Month Change

-38.17%

6 Month Change

45.95%

Ytd Change

1.89%

1 Year Change

-44.14%

3 Year Change

-64.32%

5 Year Change

-72.64%

10 Year Change

-82.98%

Max Change

-98.77%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment